Preliminary evidence of efficacy and tolerance for weekly intravenous bortezomib plus mitoxantrone in patients with advanced androgen-independent prostate cancer (AIPCa)

dc.creator	Siefker-Radtke, A. O.	en
dc.creator	Poulter, V.	en
dc.creator	Mathew, P.	en
dc.creator	Tu, S. M.	en
dc.creator	Logothetis, C. J.	en
dc.creator	Papandreou, C. N.	en
dc.date.accessioned	2015-11-23T10:47:18Z
dc.date.available	2015-11-23T10:47:18Z
dc.date.issued	2005
dc.identifier.issn	0732-183X
dc.identifier.uri	http://hdl.handle.net/11615/33011
dc.source	Journal of Clinical Oncology	en
dc.source.uri	<Go to ISI>://WOS:000230326602395
dc.subject	Oncology	en
dc.title	Preliminary evidence of efficacy and tolerance for weekly intravenous bortezomib plus mitoxantrone in patients with advanced androgen-independent prostate cancer (AIPCa)	en
dc.type	journalArticle	en

Files in questo item

Files	Dimensione	Formato	Mostra
Nessun files in questo item.